Literature DB >> 19006247

Expanded mutational spectrum in Cohen syndrome, tissue expression, and transcript variants of COH1.

Wenke Seifert1, Muriel Holder-Espinasse, Jirko Kühnisch, Kimia Kahrizi, Andreas Tzschach, Masoud Garshasbi, Hossein Najmabadi, Andreas Walter Kuss, Wolfram Kress, Geneviève Laureys, Bart Loeys, Eva Brilstra, Grazia M S Mancini, Hélène Dollfus, Karin Dahan, Kira Apse, Hans Christian Hennies, Denise Horn.   

Abstract

Cohen syndrome is characterised by mental retardation, postnatal microcephaly, facial dysmorphism, pigmentary retinopathy, myopia, and intermittent neutropenia. Mutations in COH1 (VPS13B) have been found in patients with Cohen syndrome from diverse ethnic origins. We have carried out mutation analysis in twelve novel patients with Cohen syndrome from nine families. In this series, we have identified 13 different mutations in COH1, twelve of these are novel including six frameshift mutations, four nonsense mutations, two splice site mutations, and a one-codon deletion. Since different transcripts of COH1 have been reported previously, we have analysed the expression patterns of COH1 splice variants. The transcript variant NM_152564 including exon 28b showed ubiquitous expression in all examined human tissues. In contrast, human brain and retina showed differential splicing of exon 28 (NM_017890). Moreover, analysis of mouse tissues revealed ubiquitous expression of Coh1 homologous to human NM_152564 in all examined tissues but no prevalent alternative splicing. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19006247     DOI: 10.1002/humu.20886

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  18 in total

1.  Human VPS13A is associated with multiple organelles and influences mitochondrial morphology and lipid droplet motility.

Authors:  Wondwossen M Yeshaw; Marianne van der Zwaag; Francesco Pinto; Liza L Lahaye; Anita Ie Faber; Rubén Gómez-Sánchez; Amalia M Dolga; Conor Poland; Anthony P Monaco; Sven Cd van IJzendoorn; Nicola A Grzeschik; Antonio Velayos-Baeza; Ody Cm Sibon
Journal:  Elife       Date:  2019-02-11       Impact factor: 8.140

2.  Cohen syndrome-associated protein, COH1, is a novel, giant Golgi matrix protein required for Golgi integrity.

Authors:  Wenke Seifert; Jirko Kühnisch; Tanja Maritzen; Denise Horn; Volker Haucke; Hans Christian Hennies
Journal:  J Biol Chem       Date:  2011-08-24       Impact factor: 5.157

3.  Vps13b is required for acrosome biogenesis through functions in Golgi dynamic and membrane trafficking.

Authors:  Romain Da Costa; Morgane Bordessoules; Magali Guilleman; Virginie Carmignac; Vincent Lhussiez; Hortense Courot; Amandine Bataille; Amandine Chlémaire; Céline Bruno; Patricia Fauque; Christel Thauvin; Laurence Faivre; Laurence Duplomb
Journal:  Cell Mol Life Sci       Date:  2019-06-19       Impact factor: 9.261

4.  Genome-wide linkage analysis is a powerful prenatal diagnostic tool in families with unknown genetic defects.

Authors:  Maria Arélin; Bernt Schulze; Bertram Müller-Myhsok; Denise Horn; Alexander Diers; Birgit Uhlenberg; Peter Nürnberg; Gudrun Nürnberg; Christian Becker; Stefan Mundlos; Tom H Lindner; Karl Sperling; Katrin Hoffmann
Journal:  Eur J Hum Genet       Date:  2012-10-03       Impact factor: 4.246

5.  Cohen syndrome-associated protein COH1 physically and functionally interacts with the small GTPase RAB6 at the Golgi complex and directs neurite outgrowth.

Authors:  Wenke Seifert; Jirko Kühnisch; Tanja Maritzen; Stefanie Lommatzsch; Hans Christian Hennies; Sebastian Bachmann; Denise Horn; Volker Haucke
Journal:  J Biol Chem       Date:  2014-12-09       Impact factor: 5.157

6.  Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects.

Authors:  Eunju Seong; Ryan Insolera; Marija Dulovic; Erik-Jan Kamsteeg; Joanne Trinh; Norbert Brüggemann; Erin Sandford; Sheng Li; Ayse Bilge Ozel; Jun Z Li; Tamison Jewett; Anneke J A Kievit; Alexander Münchau; Vikram Shakkottai; Christine Klein; Catherine A Collins; Katja Lohmann; Bart P van de Warrenburg; Margit Burmeister
Journal:  Ann Neurol       Date:  2018-06-30       Impact factor: 10.422

7.  Two Novel COH1 Mutations in an Italian Patient with Cohen Syndrome.

Authors:  E Athanasakis; A Fabretto; F Faletra; M Mocenigo; A Morgan; P Gasparini
Journal:  Mol Syndromol       Date:  2012-05-16

8.  Changing facial phenotype in Cohen syndrome: towards clues for an earlier diagnosis.

Authors:  Salima El Chehadeh-Djebbar; Edward Blair; Muriel Holder-Espinasse; Anne Moncla; Anne-Marie Frances; Marlène Rio; François-Guillaume Debray; Patrick Rump; Alice Masurel-Paulet; Nadège Gigot; Patrick Callier; Laurence Duplomb; Bernard Aral; Frédéric Huet; Christel Thauvin-Robinet; Laurence Faivre
Journal:  Eur J Hum Genet       Date:  2012-11-28       Impact factor: 4.246

9.  A canine model of Cohen syndrome: Trapped Neutrophil Syndrome.

Authors:  Jeremy R Shearman; Alan N Wilton
Journal:  BMC Genomics       Date:  2011-05-23       Impact factor: 3.969

10.  Novel VPS13B Mutations in Three Large Pakistani Cohen Syndrome Families Suggests a Baloch Variant with Autistic-Like Features.

Authors:  Muhammad Arshad Rafiq; Claire S Leblond; Muhammad Arif Nadeem Saqib; Akshita K Vincent; Amirthagowri Ambalavanan; Falak Sher Khan; Muhammad Ayaz; Naseema Shaheen; Dan Spiegelman; Ghazanfar Ali; Muhammad Amin-ud-Din; Sandra Laurent; Huda Mahmood; Mehtab Christian; Nadir Ali; Alanna Fennell; Zohair Nanjiani; Gerald Egger; Chantal Caron; Ahmed Waqas; Muhammad Ayub; Saima Rasheed; Baudouin Forgeot d'Arc; Amelie Johnson; Joyce So; Muhammad Qasim Brohi; Laurent Mottron; Muhammad Ansar; John B Vincent; Lan Xiong
Journal:  BMC Med Genet       Date:  2015-06-25       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.